Bionovate Technologies Corp
BIIO
$0.0001
$0.000.00%
OTC PK
| 09/30/2021 | 06/30/2021 | 03/31/2021 | 12/31/2020 | 09/30/2020 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -- | -- | -- | -- | -- |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -- | -- | -- | -- | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -- | -- | -- | -- | -- |
|
|
|||||
| Total Current Assets | -- | -- | -- | -- | -- |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | -- | -- | -- | -- | -- |
|
|
|||||
| Total Accounts Payable | 38.10K | 32.00K | 33.90K | 47.50K | 38.10K |
| Total Accrued Expenses | 208.20K | 192.80K | 177.70K | 162.60K | 151.20K |
| Short-term Debt | 278.60K | 278.40K | 272.10K | 241.90K | 230.20K |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 524.80K | 503.20K | 483.60K | 452.00K | 419.50K |
|
|
|||||
| Total Current Liabilities | 524.80K | 503.20K | 483.60K | 452.00K | 419.50K |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | 278.60K | 278.40K | 272.10K | 241.90K | 230.20K |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 524.80K | 503.20K | 483.60K | 452.00K | 419.50K |
|
|
|||||
| Common Stock & APIC | 2.30M | 2.30M | 2.30M | 2.30M | 2.30M |
| Retained Earnings | -2.83M | -2.80M | -2.79M | -2.75M | -2.72M |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | -524.80K | -503.20K | -483.60K | -452.00K | -419.50K |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -524.80K | -503.20K | -483.60K | -452.00K | -419.50K |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -524.80K | -503.20K | -483.60K | -452.00K | -419.50K |
|
|
|||||